Annual number needed to treat across cardiovascular drugs approved from 2010 to 2024: A descriptive analysis of pivotal studies.

Strauss BJ

Open source

DOI
10.1016/j.ahjo.2026.100910
Published
2026 Nov
Container
American heart journal plus : cardiology research and practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ahjo.2026.100910,
  title = {Annual number needed to treat across cardiovascular drugs approved from 2010 to 2024: A descriptive analysis of pivotal studies.},
  author = {Strauss BJ},
  year = {2026},
  journal = {American heart journal plus : cardiology research and practice},
  doi = {10.1016/j.ahjo.2026.100910},
  url = {https://doi.org/10.1016/j.ahjo.2026.100910}
}

RIS

TY  - JOUR
TI  - Annual number needed to treat across cardiovascular drugs approved from 2010 to 2024: A descriptive analysis of pivotal studies.
AU  - Strauss BJ
PY  - 2026
JO  - American heart journal plus : cardiology research and practice
DO  - 10.1016/j.ahjo.2026.100910
UR  - https://doi.org/10.1016/j.ahjo.2026.100910
ER  - 

APA

BJ, S. (2026). Annual number needed to treat across cardiovascular drugs approved from 2010 to 2024: A descriptive analysis of pivotal studies.. American heart journal plus : cardiology research and practice. https://doi.org/10.1016/j.ahjo.2026.100910

Source records